Literature DB >> 12575859

Prevalence of onychomycosis in Iceland: a population-based study.

Bárdur Sigurgeirsson, Olafur Steingrímsson, Snjólaug Sveinsdóttir.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12575859     DOI： 10.1080/000155502762064665

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  6 in total

1.  In vitro antifungal activity of ME1111, a new topical agent for onychomycosis, against clinical isolates of dermatophytes.

Authors:  M Ghannoum; N Isham; L Long
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

2.  Toenail onychomycosis in a Portuguese geriatric population.

Authors:  N Dias; C Santos; M Portela; N Lima
Journal:  Mycopathologia       Date:  2011-03-02       Impact factor: 2.574

3.  Ciclopirox 8% HPCH Nail Lacquer in the Treatment of Mild-to-Moderate Onychomycosis: A Randomized, Double-Blind Amorolfine Controlled Study Using a Blinded Evaluator.

Authors:  Matilde Iorizzo; Ilona Hartmane; Andra Derveniece; Ingmars Mikazans
Journal:  Skin Appendage Disord       Date:  2015-11-07

4.  A Case Series of Severe Hospitalized COVID-19 Patients Treated with Tocilizumab and Glucocorticoids: A Report from Saudi Arabian Hospital.

Authors:  Salma AlBahrani; Jaffar A Al-Tawfiq; Abdulaziz R Alshaer; Amal Shilash; Khalid Alswefy; Razan Salamah Al-Zayer; Amr Mohamed Abouelela
Journal:  J Epidemiol Glob Health       Date:  2021-01-22

5.  Epidemiology of Dermatophytes Isolated from Clinical Samples in a Hospital in Eastern Saudi Arabia: A 20-Year Survey.

Authors:  Bashayer Ali Alshehri; Aisha M Alamri; Ali A Rabaan; Jaffar A Al-Tawfiq
Journal:  J Epidemiol Glob Health       Date:  2021-09-16

6.  The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients.

Authors:  Güven Kuvandik; Meryem Cetin; Gultekin Genctoy; Mehmet Horoz; Mehmet Duru; Cenk Akcali; Salim Satar; Ahmet A Kiykim; Hasan Kaya
Journal:  BMC Infect Dis       Date:  2007-08-30       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.